Editas Medicine Management
Management criteria checks 2/4
Editas Medicine's CEO is Gilmore O’Neill, appointed in Jun 2022, has a tenure of 1.83 years. total yearly compensation is $2.39M, comprised of 26.8% salary and 73.2% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth $506.29K. The average tenure of the management team and the board of directors is 1.4 years and 4.3 years respectively.
Key information
Gilmore O’Neill
Chief executive officer
US$2.4m
Total compensation
CEO salary percentage | 26.8% |
CEO tenure | 1.8yrs |
CEO ownership | 0.1% |
Management average tenure | 1.4yrs |
Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$2m | US$641k | -US$153m |
Sep 30 2023 | n/a | n/a | -US$195m |
Jun 30 2023 | n/a | n/a | -US$206m |
Mar 31 2023 | n/a | n/a | -US$219m |
Dec 31 2022 | US$9m | US$356k | -US$220m |
Compensation vs Market: Gilmore's total compensation ($USD2.39M) is above average for companies of similar size in the UK market ($USD1.05M).
Compensation vs Earnings: Gilmore's compensation has been consistent with company performance over the past year.
CEO
Gilmore O’Neill (59 yo)
1.8yrs
Tenure
US$2,392,309
Compensation
Dr. Gilmore O’Neill, M. B., M. M.SC., serves as Member of Scientific Advisory Board of AavantiBio, Inc. since February 2022. He is President & CEO of Editas Medicine, Inc. from June 01, 2022 and serves as...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 1.8yrs | US$2.39m | 0.11% $ 506.3k | |
CFO & Executive VP | less than a year | US$2.69m | 0% $ 0 | |
Executive VP & Chief Scientific Officer | less than a year | US$1.73m | 0% $ 0 | |
Executive VP & Chief Medical Officer | 1.8yrs | US$1.14m | 0.041% $ 179.2k | |
Co-Founder & Scientific Advisory Board Member | 11.3yrs | no data | no data | |
Co-Founder & Scientific Advisory Board Member | 11.3yrs | no data | no data | |
Corporate Communications & Investor Relations | no data | no data | no data | |
Executive VP & General Counsel | no data | no data | no data | |
Executive VP & Chief People Officer | 1.1yrs | no data | no data | |
Executive VP and Chief Commercial & Strategy Officer | less than a year | no data | no data |
1.4yrs
Average Tenure
59yo
Average Age
Experienced Management: 0IFK's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | no data | US$2.39m | 0.11% $ 506.3k | |
Co-Founder & Scientific Advisory Board Member | no data | no data | no data | |
Co-Founder & Scientific Advisory Board Member | no data | no data | no data | |
Independent Chairman of the Board | 2.6yrs | US$238.24k | 0% $ 0 | |
Independent Director | 7.8yrs | US$208.06k | 0% $ 0 | |
Independent Director | 6.9yrs | US$210.56k | 0.0024% $ 10.7k | |
Independent Lead Director | 6.2yrs | US$231.07k | 0.028% $ 121.9k | |
Independent Director | less than a year | no data | 0% $ 0 | |
Independent Director | 5.2yrs | US$213.06k | 0% $ 0 | |
Independent Director | 2.5yrs | US$215.06k | 0% $ 0 | |
Independent Director | 3.3yrs | US$205.56k | 0% $ 0 |
4.3yrs
Average Tenure
63.5yo
Average Age
Experienced Board: 0IFK's board of directors are considered experienced (4.3 years average tenure).